178 related articles for article (PubMed ID: 30577600)
21. Increased Intracellular Reactive Oxygen Species Mediates the Anti-Cancer Effects of WZ35 via Activating Mitochondrial Apoptosis Pathway in Prostate Cancer Cells.
Chen M; Zhou B; Zhong P; Rajamanickam V; Dai X; Karvannan K; Zhou H; Zhang X; Liang G
Prostate; 2017 Apr; 77(5):489-504. PubMed ID: 27990666
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, oxidant properties, and antitumoral effects of a heteroleptic palladium(II) complex of curcumin on human prostate cancer cells.
Valentini A; Conforti F; Crispini A; De Martino A; Condello R; Stellitano C; Rotilio G; Ghedini M; Federici G; Bernardini S; Pucci D
J Med Chem; 2009 Jan; 52(2):484-91. PubMed ID: 19113979
[TBL] [Abstract][Full Text] [Related]
23. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
24. A new class of hybrid anticancer agents inspired by the synergistic effects of curcumin and genistein: Design, synthesis, and anti-proliferative evaluation.
Chen QH; Yu K; Zhang X; Chen G; Hoover A; Leon F; Wang R; Subrahmanyam N; Addo Mekuria E; Harinantenaina Rakotondraibe L
Bioorg Med Chem Lett; 2015 Oct; 25(20):4553-6. PubMed ID: 26341135
[TBL] [Abstract][Full Text] [Related]
25. Effect of diallyl disulfide on insulin-like growth factor signaling molecules involved in cell survival and proliferation of human prostate cancer cells in vitro and in silico approach through docking analysis.
Arunkumar R; Sharmila G; Elumalai P; Senthilkumar K; Banudevi S; Gunadharini DN; Benson CS; Daisy P; Arunakaran J
Phytomedicine; 2012 Jul; 19(10):912-23. PubMed ID: 22739413
[TBL] [Abstract][Full Text] [Related]
26. Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression.
Nakamae I; Morimoto T; Shima H; Shionyu M; Fujiki H; Yoneda-Kato N; Yokoyama T; Kanaya S; Kakiuchi K; Shirai T; Meiyanto E; Kato JY
Molecules; 2019 Nov; 24(22):. PubMed ID: 31717651
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
[TBL] [Abstract][Full Text] [Related]
28. Prostate cancer and curcumin: add spice to your life.
Aggarwal BB
Cancer Biol Ther; 2008 Sep; 7(9):1436-40. PubMed ID: 18769126
[No Abstract] [Full Text] [Related]
29. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line.
Raja Singh P; Arunkumar R; Sivakamasundari V; Sharmila G; Elumalai P; Suganthapriya E; Brindha Mercy A; Senthilkumar K; Arunakaran J
Cell Biochem Funct; 2014 Apr; 32(3):217-28. PubMed ID: 23963693
[TBL] [Abstract][Full Text] [Related]
30. Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1.
Li W; Pung D; Su ZY; Guo Y; Zhang C; Yang AY; Zheng X; Du ZY; Zhang K; Kong AN
Chem Res Toxicol; 2016 Apr; 29(4):694-703. PubMed ID: 26991801
[TBL] [Abstract][Full Text] [Related]
31. Mannich Curcuminoids as Potent Anticancer Agents.
Gyuris M; Hackler L; Nagy LI; Alföldi R; Rédei E; Marton A; Vellai T; Faragó N; Ózsvári B; Hetényi A; Tóth GK; Sipos P; Kanizsai I; Puskás LG
Arch Pharm (Weinheim); 2017 Jul; 350(7):. PubMed ID: 28547897
[TBL] [Abstract][Full Text] [Related]
32. Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation.
Zou P; Xia Y; Chen T; Zhang J; Wang Z; Chen W; Chen M; Kanchana K; Yang S; Liang G
Mol Carcinog; 2016 Jun; 55(6):1073-86. PubMed ID: 26086416
[TBL] [Abstract][Full Text] [Related]
33. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
Deng G; Yu JH; Ye ZQ; Hu ZQ
Zhonghua Nan Ke Xue; 2008 Feb; 14(2):116-21. PubMed ID: 18390174
[TBL] [Abstract][Full Text] [Related]
34. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.
Mbese Z; Khwaza V; Aderibigbe BA
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801262
[TBL] [Abstract][Full Text] [Related]
35. Curcumin-based anti-prostate cancer agents.
Chen QH
Anticancer Agents Med Chem; 2015; 15(2):138-56. PubMed ID: 25594891
[TBL] [Abstract][Full Text] [Related]
36. Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis.
Cao H; Yu H; Feng Y; Chen L; Liang F
Cancer Chemother Pharmacol; 2017 May; 79(5):985-994. PubMed ID: 28391351
[TBL] [Abstract][Full Text] [Related]
37. Anti-proliferative effect and induction of apoptosis in androgen-independent human prostate cancer cells by 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one.
Citalingam K; Abas F; Lajis NH; Othman I; Naidu R
Molecules; 2015 Feb; 20(2):3406-30. PubMed ID: 25690296
[TBL] [Abstract][Full Text] [Related]
38. Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway.
Xu X; Qin J; Liu W
Gene; 2014 Aug; 546(2):226-32. PubMed ID: 24910117
[TBL] [Abstract][Full Text] [Related]
39. Optimization of diarylpentadienones as chemotherapeutics for prostate cancer.
Patanapongpibul M; Zhang C; Chen G; Guo S; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2018 Sep; 26(16):4751-4760. PubMed ID: 30121214
[TBL] [Abstract][Full Text] [Related]
40. Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells.
Waghela BN; Sharma A; Dhumale S; Pandey SM; Pathak C
PLoS One; 2015; 10(2):e0117526. PubMed ID: 25692854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
